Stories

The IRE Resource Center is a major research library containing more than 27,000 investigative stories.

Most of our stories are not available for download but can be easily ordered by contacting the Resource Center directly at 573-882-3364 or rescntr@ire.org where a researcher can help you pinpoint what you need.

Search results for "Roaches" ...

  • Subsidized Squalor

    The residents of Richmond’s public housing had given up. They used to speak up when things got bad. But they’d long ago stopped believing anyone would listen. They resigned themselves to sharing their bedrooms with cockroaches and bedbugs and ceding their common areas to criminals. Deep down, the frustration simmered. It finally came spilling out with fury after The Center for Investigative Reporting’s Amy Julia Harris exposed the squalid conditions in Richmond public housing, giving those residents the voice they’d lost.
  • Poor Health An occasional series about the barriers to health and health care for low-income urban Americans

    Poor Health was the result of a collaboration between the Pittsburgh Post-Gazette, the Milwaukee Journal Sentinel and faculty and students from Marquette University. Both papers published the series, which had three major parts. The backbone of the series is a set of interactive maps that shows that health care systems have closed hospitals in poor communities in the major U.S. metropolitan areas while opening new facilities in more affluent areas, often communities that already had hospitals; that the residents of the communities in which hospitals closed were less healthy than their more affluent counterparts, and that communities in which hospitals closed were much more likely to be federally designated "physician shortage areas." than communities that retained or gained hospitals. In addition, reporting in several cities shows the health care challenges among the urban poor, the results of those difficulties and the economics that drive the unequal distribution of health care. The final part of the series focuses on solutions. A major story on the effort in Oregon to improve health care for Medicaid recipients while lowering costs is the centerpiece; other reporting on innovative approaches to health care in poor areas includes programs in Philadelphia, Cleveland and Indianapolis.
  • LA Times: Playing on Fear: A Costly Bioterrorism Program Fails to Protect

    The topic was bioterrorism and BioWatch, a critical civilian defense system that, it turns out, has never worked. The stories demonstrate how fear of terrorism—and U.S. officials’ fear of appearing “soft” on terrorism—have saddled the country and taxpayers with a failed system. As the articles point out, the nation’s decade-long commitment to BioWatch has come at the expense of other approaches to biodefense that hold more promise for saving lives.
  • Elders Unprotected

    The series examines how state inspectors overlooked and ignored complaints coming from nursing homes. Reports included residents left in their own feces and urine and cockroaches rampant throughout the nursing homes.
  • Puppy Pipeline

    The Post tracked a puppy mill pipeline stretching from the Ozarks to South Florida, one that brought thousands of sometimes-sick puppies from mass-operations to local pet stores. At least 2,500 puppies were delivered to Palm Beach, Martin and St. Lucie counties from out-of-states breeders in an 11-month period. Roughly one in three of those came from breeders or distributors cited for problems by the U.S. Department of Agriculture, which oversees wholesale dog breeding. Citations varied from keeping animals in too-small and rusting cages with exposed nails or wires, to caked feces, to infestations of roaches and other insects that covered the walls and ceilings of kennels. In dozens of cases, kennel owners averted USDA inspection entirely.
  • "Unique Approaches to Uncover the Size and Growth of Executive Pay and Pensions"

    While employees throughout the U.S. experienced pay cuts or were laid off, top executives were receiving millions of dollars in bonuses. Reporters Ellen Schultz and Tom McGinty dig deep to find out exactly how extreme those payouts have become.
  • Poor Schools, Rich Targets

    "No Child Left Behind legislation created a bonanza for educational technology companies. Pitching products they claim will raise test scores, these firms find willing buyers in poor school systems desperate to comply with the law. The law provides major federal funding for purchasing these products but with no guidance on which work. Truth is, as the series revealed, many products appear to do little for children despite what the companies promise. At worst, reliance on education by computer takes valuable time and resources away from more effective teaching approaches."
  • Who's Hispanic?

    A lack of precise definition of the word "hispanic" has caused confusion and some ruffles in the past. The National Journal chronicles the various definitions and approaches to "hispanic" and reasons as to why Alberto Gonzales might be Bush's favorite candidate for the Supreme Court, after all. The author explains in detail why the Portuguese and the Haitians have still not been included under the now-famous umbrella of "hispanics".
  • Profoting From Fine Print With Wall Street's Help

    The Times reports on questionable approaches used by First Alliance, a national home-equity lender. The story looks at the complaints of hundreds of consumers that the "company has used a deceptive sales pitch, delivered by loan officers recruited from big auto dealerships, to lure homeowners into high-cost loans that expose them to the threat of foreclosure and financial ruin."
  • The Stalling Game

    Consumer Report looks at how "sweetheart deals and patent extensions keep lower-cost generic drugs from consumers." The story lists several approaches that both generic manufacturers and brand-name companies have used to gain and keep market exclusivity. These include: "sneaking patent-existing riders into complex and unrelated legislative procedures; paying chemical supply houses not to sell needed ingredients to rival drug manufacturers; paying competitors to stay out of the market; filing unfounded "citizen petitions" and patents to delay the marketing of a generic drug." The reporter points to specific examples of how pharmaceutical companies have taken advantage of loopholes in current law.